Journal
FRONTIERS IN CARDIOVASCULAR MEDICINE
Volume 9, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fcvm.2022.970036
Keywords
hypertension; intestinal microbiota; intestinal dysbiosis; SCFAs; inflammation
Categories
Funding
- Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine
Ask authors/readers for more resources
Intestinal microbiota and its metabolites play an important role in the development of hypertension, and the limitations and challenges in this field provide directions for future research. Modulating intestinal microbes and metabolites can lead to the development of accurate and personalized preventive and therapeutic strategies.
Hypertension has developed into an escalating serious global public health problem with multiple and unclear pathophysiological mechanisms. Recent studies have identified intestinal microbiota as a key perpetrator of hypertension through a variety of mechanisms. In this review, we highlight the potential roles of the intestinal microbiota and its metabolites in the development of hypertension, as well as the therapeutic potential for targeting intestinal microbiomes. We also shed light on the main limitations and challenges of the current research and suggest directions for future investigations. Finally, we discuss the development of accurate and personalized preventive and therapeutic strategies for hypotension by the modulation of intestinal microbes and metabolites.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available